Last reviewed · How we verify

Any oral opioid

Montefiore Medical Center · Phase 2 active Small molecule

Activates opioid receptors in the brain to produce analgesia.

Activates opioid receptors in the brain to produce analgesia. Used for Chronic pain, Acute pain.

At a glance

Generic nameAny oral opioid
SponsorMontefiore Medical Center
Drug classOpioid
TargetOpioid receptor
ModalitySmall molecule
Therapeutic areaPain
PhasePhase 2

Mechanism of action

Opioid receptors are G protein-coupled receptors that, when activated, can lead to a variety of downstream effects including analgesia, euphoria, and respiratory depression. Activation of these receptors can also lead to physical dependence and addiction.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: